Owner Novartis AG

Inventors Grenet, Olivier; Kehren, Jeanne; Wolfgang, Curt Douglas; Stadtler. Frank; Imbert, Georges; Chibout, Salah-Dine

Agent Davies Collison Cave

Pub. Number AU-B-2003250879

PCT Number PCT/EP03/07111

PCT Pub. Number WO2004/005544

Priority 0215509.1 04.07.02 GB

Filing date 3 July 2003

Wipo publication date 23 January 2004

Acceptance publication date 26 July 2007

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids